ATE412006T1 - Anti-retrovirale immunogene, ihre darstellung und verwendung - Google Patents

Anti-retrovirale immunogene, ihre darstellung und verwendung

Info

Publication number: ATE412006T1
Authority: AT; Austria
Prior art keywords: immunogenes; retroviral; presentation; retroviral immunogenes
Prior art date: 1997-12-26

Application number

AT98964219T

Other languages

English (en)

Inventor

Jean-Francois Zagury

Jay Rappaport

Miguel Carcagno

Original Assignee

Neovacs

Biovacs Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-26

Filing date

1998-12-22

Publication date

2008-11-15

1998-12-22 Application filed by Neovacs, Biovacs Inc filed Critical Neovacs

2008-11-15 Application granted granted Critical

2008-11-15 Publication of ATE412006T1 publication Critical patent/ATE412006T1/de

Links

230000000798 anti-retroviral effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

AT98964219T 1997-12-26 1998-12-22 Anti-retrovirale immunogene, ihre darstellung und verwendung ATE412006T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9716589A FR2773156B1 (fr)	1997-12-26	1997-12-26	Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida

Publications (1)

Publication Number	Publication Date
ATE412006T1 true ATE412006T1 (de)	2008-11-15

Family

ID=9515202

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT98959984T ATE330970T1 (de)	1997-12-26	1998-12-14	Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids
AT98964219T ATE412006T1 (de)	1997-12-26	1998-12-22	Anti-retrovirale immunogene, ihre darstellung und verwendung

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT98959984T ATE330970T1 (de)	1997-12-26	1998-12-14	Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids

Country Status (16)

Country	Link
US (2)	US6420141B1 (de)
EP (3)	EP1042363B1 (de)
JP (2)	JP2001527029A (de)
AR (1)	AR014946A1 (de)
AT (2)	ATE330970T1 (de)
AU (2)	AU1568499A (de)
BR (1)	BR9814473A (de)
CA (1)	CA2316811A1 (de)
CY (1)	CY1106152T1 (de)
DE (2)	DE69835031T2 (de)
DK (1)	DK1042363T3 (de)
ES (1)	ES2267199T3 (de)
FR (1)	FR2773156B1 (de)
MX (1)	MXPA00006263A (de)
PT (1)	PT1042363E (de)
WO (2)	WO1999033872A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2773156B1 (fr)	1997-12-26	2000-03-31	Biovacs Inc	Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
FR2781158B1 (fr)	1998-07-15	2002-12-13	Vacs Internat	Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications
AU2221600A (en)	1998-12-31	2000-07-31	Chiron Corporation	Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en)	1998-12-31	2000-07-31	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
FR2792639B1 (fr)	1999-04-26	2003-06-06	Neovacs	Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
US20050226890A1 (en) *	1999-08-12	2005-10-13	Cohen David I	Tat-based vaccine compositions and methods of making and using same
BR0107972A (pt) *	2000-01-31	2002-11-05	Smithkline Beecham Biologicals	Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
US20080044435A1 (en) *	2004-03-16	2008-02-21	Cohen David I	Tat-Based Tolerogen Compositions and Methods of Making and Using Same
NO314587B1 (no) *	2000-09-04	2003-04-14	Bionor Immuno As	HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV
EP1411770A4 (de)	2001-07-05	2006-05-10	Chiron Corp	Polynukleotide, die für antigene hiv-polypeptide des c-typs codieren, polypeptide und ihre verwendung
FR2828404B1 (fr) *	2001-08-10	2005-07-15	Neovacs	Superimmunogene composite a usage vaccinal bifonctionnel pour le traitement des maladies associees a un desordre tissulaire stromal
US20030170614A1 (en)	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2002358181A1 (en) *	2001-12-11	2003-07-09	Aventis Pasteur	Mutated hiv tat
UA82998C2 (ru) *	2002-05-16	2008-06-10	Бавариан Нордик А/С	Экспрессия генов в модифицированном вирусе коровьей оспы ankara с использованием коровьего поксвирусного промотора аті
US20040115830A1 (en) *	2002-09-25	2004-06-17	Igor Touzov	Components for nano-scale Reactor
FR2862306B1 (fr)	2003-11-17	2008-05-30	Aventis Pasteur	Composition vaccinale
US7927580B2 (en) *	2004-03-16	2011-04-19	Nanirx, Inc.	Tat-based immunomodulatory compositions and methods of their discovery and use
AR054822A1 (es)	2005-07-07	2007-07-18	Sanofi Pasteur	Emulsion inmuno adyuvante
US8168165B2 (en) *	2008-12-23	2012-05-01	Abbott Laboratories	Alkylated interleukin-18 compositions
EP2411043B1 (de)	2009-03-23	2013-07-31	PIN Pharma, Inc.	Krebsbehandlung mit immunstimulierenden hiv-tat-derivat-polypeptiden
AU2011230619C1 (en)	2010-03-25	2016-06-23	Oregon Health & Science University	CMV glycoproteins and recombinant vectors
HUE037408T2 (hu)	2011-06-10	2018-08-28	Univ Oregon Health & Science	CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en)	2011-09-12	2013-03-12	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
ES2631608T3 (es)	2012-06-27	2017-09-01	International Aids Vaccine Initiative	Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
CN105705164A (zh)	2013-10-04	2016-06-22	品诺制药公司	用于癌症治疗的免疫刺激性hiv tat衍生多肽
US10058604B2 (en)	2013-10-07	2018-08-28	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
AU2015305690A1 (en) *	2014-08-18	2017-03-02	Sanofi Pasteur Inc.	Alkylated influenza vaccines
EP3069730A3 (de)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en)	2015-03-23	2018-04-03	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
FR3057438B1 (fr)	2016-10-14	2020-10-02	Univ Limoges	Procede d'elicitation d'une plante au moyen d'extraits de champignons macroscopiques comestibles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4258029A (en)	1979-04-23	1981-03-24	Connaught Laboratories Limited	Synthetic adjuvants for stimulation of antigenic responses
US4235877A (en)	1979-06-27	1980-11-25	Merck & Co., Inc.	Liposome particle containing viral or bacterial antigenic subunit
EP0220273B2 (de)	1985-04-29	2007-01-17	Bio-Rad Laboratories, Inc.	Synthetische antigene zum nachweis von aids
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
WO1991018454A1 (en) *	1990-05-18	1991-11-28	Centre National De La Recherche Scientifique	Compositions capable of blocking cytotoxicity of viral regulatory proteins and neurotoxic symptoms associated with retroviral infection
WO1994015634A1 (en) *	1992-12-30	1994-07-21	Matthias Rath	Tat and rev oligopeptides in hiv treatment
WO1995031999A1 (en)	1994-05-23	1995-11-30	Immunogiology Research Institute, Inc.	Compositions of transactivating proteins of human immunodeficiency virus
ATE196255T1 (de) *	1995-03-08	2000-09-15	Neovacs	Von einem retroviralen regulationsprotein abstammende, detoxifierte immunogene, dagegen gerichtete antikörper, verfahren zur deren herstellung und diese immunogene oder antikörper enthaltende, pharmazeutische zusammensetzungen.
US6200575B1 (en) *	1996-03-07	2001-03-13	Neovacs	Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them
FR2773156B1 (fr)	1997-12-26	2000-03-31	Biovacs Inc	Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida

1997
- 1997-12-26 FR FR9716589A patent/FR2773156B1/fr not_active Expired - Fee Related
1998
- 1998-12-14 EP EP98959984A patent/EP1042363B1/de not_active Expired - Lifetime
- 1998-12-14 DK DK98959984T patent/DK1042363T3/da active
- 1998-12-14 US US09/582,519 patent/US6420141B1/en not_active Expired - Lifetime
- 1998-12-14 AU AU15684/99A patent/AU1568499A/en not_active Abandoned
- 1998-12-14 AT AT98959984T patent/ATE330970T1/de active
- 1998-12-14 PT PT98959984T patent/PT1042363E/pt unknown
- 1998-12-14 DE DE69835031T patent/DE69835031T2/de not_active Expired - Lifetime
- 1998-12-14 WO PCT/FR1998/002727 patent/WO1999033872A1/fr not_active Ceased
- 1998-12-14 ES ES98959984T patent/ES2267199T3/es not_active Expired - Lifetime
- 1998-12-22 EP EP98964219A patent/EP1041888B1/de not_active Expired - Lifetime
- 1998-12-22 AU AU19397/99A patent/AU1939799A/en not_active Abandoned
- 1998-12-22 DE DE69840152T patent/DE69840152D1/de not_active Expired - Fee Related
- 1998-12-22 WO PCT/US1998/027263 patent/WO1999033346A1/en not_active Ceased
- 1998-12-22 MX MXPA00006263A patent/MXPA00006263A/es not_active IP Right Cessation
- 1998-12-22 BR BR9814473-1A patent/BR9814473A/pt not_active Application Discontinuation
- 1998-12-22 EP EP07123075A patent/EP1975173A1/de not_active Withdrawn
- 1998-12-22 AT AT98964219T patent/ATE412006T1/de not_active IP Right Cessation
- 1998-12-22 CA CA002316811A patent/CA2316811A1/en not_active Abandoned
- 1998-12-22 JP JP2000526120A patent/JP2001527029A/ja active Pending
- 1998-12-23 AR ARP980106645A patent/AR014946A1/es active IP Right Grant
2000
- 2000-05-17 US US09/572,451 patent/US7022326B1/en not_active Expired - Fee Related
2006
- 2006-06-09 JP JP2006161682A patent/JP2006257102A/ja active Pending
- 2006-08-31 CY CY20061101235T patent/CY1106152T1/el unknown

Also Published As

Publication number	Publication date
US7022326B1 (en)	2006-04-04
DE69835031D1 (de)	2006-08-03
US6420141B1 (en)	2002-07-16
DE69840152D1 (de)	2008-12-04
WO1999033346A1 (en)	1999-07-08
FR2773156B1 (fr)	2000-03-31
AU1939799A (en)	1999-07-19
JP2001527029A (ja)	2001-12-25
EP1042363A1 (de)	2000-10-11
DK1042363T3 (da)	2006-10-30
FR2773156A1 (fr)	1999-07-02
CY1106152T1 (el)	2011-06-08
AU1568499A (en)	1999-07-19
BR9814473A (pt)	2001-10-23
CA2316811A1 (en)	1999-07-08
ATE330970T1 (de)	2006-07-15
EP1975173A1 (de)	2008-10-01
EP1042363B1 (de)	2006-06-21
JP2006257102A (ja)	2006-09-28
EP1041888B1 (de)	2008-10-22
MXPA00006263A (es)	2003-07-14
WO1999033872A1 (fr)	1999-07-08
AR014946A1 (es)	2001-04-11
EP1041888A4 (de)	2000-10-18
PT1042363E (pt)	2006-11-30
DE69835031T2 (de)	2007-01-18
EP1041888A1 (de)	2000-10-11
ES2267199T3 (es)	2007-03-01

Legal Events

Date	Code	Title	Description
2009-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE412006T1 (de)	2008-11-15	Anti-retrovirale immunogene, ihre darstellung und verwendung
DE69720389D1 (de)	2003-05-08	Zementzusammensetzungen und ihre Verwendung
DE69713379D1 (de)	2002-07-18	Zusammensetzungen auf basis von sphingomyelinase und ihre verwendung
EP1021185A4 (de)	2005-09-07	Dihydropyrimidine und ihre verwendungen.
ATE424202T1 (de)	2009-03-15	Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
ATA188592A (de)	1995-12-15	Alkyl-bisacylphosphinoxide, diese enthaltende zusammensetzungen und ihre verwendung
DE60127997D1 (de)	2007-05-31	1,5-benzothiazepine und ihre verwendung als antihyperlipidämika
DE69820397D1 (de)	2004-01-22	Ätzmittel und ihre Verwendung
DE59712887D1 (de)	2007-11-22	Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE69637691D1 (de)	2008-11-06	Azeotropähnliche zusammensetzungen und ihre verwendung
DE69638056D1 (de)	2009-11-26	Azeotropähnliche zusammensetzungen und ihre verwendung
DE60027479D1 (de)	2006-05-24	Harzstruktur und ihre verwendung
DE69840599D1 (de)	2009-04-09	Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
ATE448238T1 (de)	2009-11-15	3-beta-d-ribofuranosylthiazolo(4,5- delta)pyridimin-nucleoside und ihre verwendung
ATE251892T1 (de)	2003-11-15	Schäumende öl-zusammensetzung und ihre verwendung
DE69922986D1 (de)	2005-02-03	Substituierte phenylderivate, ihre herstellung und verwendung
ATE258549T1 (de)	2004-02-15	Oxazolidindion-derivate, ihre herstellung und verwendung
DE60016326D1 (de)	2005-01-05	Wasser-absorbierende Zusammensetzung und ihre Verwendung
DE69814431D1 (de)	2003-06-12	3,3-diarylpropylamine , ihre verwendung und herstellung
DE60027927D1 (de)	2006-06-14	Harzstruktur und ihre verwendung
DE69835433D1 (de)	2006-09-14	Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
DE69620914D1 (de)	2002-05-29	Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69810521D1 (de)	2003-02-13	Abbeizzusammensetzungen, ihre Herstellung und Verwendung
ATE212346T1 (de)	2002-02-15	3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung
EP0617088A3 (de)	1995-06-07	Ternäre Polymermischung und ihre Verwendung.